Ambu A/S (AMBBY)
OTCMKTS · Delayed Price · Currency is USD
12.94
0.00 (0.00%)
At close: Feb 11, 2026
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of $3.48 billion as of February 12, 2026. Its market cap has decreased by -31.35% in one year.
Market Cap
3.48B
Enterprise Value
3.45B
Revenue
956.63M
Ranking
n/a
PE Ratio
40.69
Stock Price
$12.94
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 46.64M to 3.48B, an increase of 7,360.48%. That is a compound annual growth rate of 14.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.65B | -0.98% |
| Dec 30, 2025 | 3.69B | -4.34% |
| Dec 30, 2024 | 3.86B | -7.19% |
| Dec 29, 2023 | 4.15B | 27.87% |
| Dec 30, 2022 | 3.25B | -51.40% |
| Dec 30, 2021 | 6.68B | -37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Vivos | 32.75M |
| Guided Therapeutics | 28.51M |